From Bio Co.,Ltd (KOSDAQ:377220)
South Korea
· Delayed Price · Currency is KRW 2,190.00
+50.00 (2.34%)
At close: May 8, 2025, 3:30 PM KST
From Bio Co.,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -25,288 | -11,076 | 3,241 | 11,282 |
| Depreciation & Amortization | 2,295 | 1,645 | 1,142 | 1,072 |
| Loss (Gain) From Sale of Assets | -364.17 | -9.84 | 20.76 | 12.09 |
| Loss (Gain) From Sale of Investments | 85.98 | -125.03 | 0.06 | 2.84 |
| Provision & Write-off of Bad Debts | 16.43 | 176.29 | 4.81 | -4.99 |
| Other Operating Activities | 7,166 | -2,957 | -3,310 | -4,909 |
| Change in Accounts Receivable | -1,129 | -146.02 | 1,876 | 490.85 |
| Change in Inventory | 872.88 | -3,654 | -1,325 | -9,275 |
| Change in Accounts Payable | 2,100 | -872.77 | -2,164 | -370.58 |
| Change in Unearned Revenue | 22.27 | - | - | - |
| Change in Income Taxes | 126.46 | -141.44 | - | - |
| Change in Other Net Operating Assets | -603.91 | -3,684 | -1,509 | 524.18 |
| Operating Cash Flow | -14,700 | -20,845 | -2,023 | -1,175 |
| Capital Expenditures | -893.42 | -16,656 | -13,589 | -8,781 |
| Sale of Property, Plant & Equipment | 10.64 | 8 | 4 | 70.1 |
| Sale (Purchase) of Intangibles | 1,876 | -40.59 | -1,594 | -2,388 |
| Investment in Securities | 1,307 | 22,728 | 10,983 | -30,968 |
| Other Investing Activities | 298.75 | 1,288 | -687.7 | -19.61 |
| Investing Cash Flow | 2,598 | 7,328 | -4,934 | -42,086 |
| Short-Term Debt Issued | 4,400 | 18,400 | - | - |
| Long-Term Debt Issued | 4,500 | - | - | - |
| Total Debt Issued | 8,900 | 18,400 | - | - |
| Short-Term Debt Repaid | -1,000 | - | - | -1,000 |
| Long-Term Debt Repaid | -258.44 | -250.2 | -335.71 | -2,834 |
| Total Debt Repaid | -1,258 | -250.2 | -335.71 | -3,834 |
| Net Debt Issued (Repaid) | 7,642 | 18,150 | -335.71 | -3,834 |
| Issuance of Common Stock | - | - | - | 47,660 |
| Other Financing Activities | -21.79 | -0 | 980 | -0 |
| Financing Cash Flow | 7,620 | 18,150 | 644.29 | 43,826 |
| Foreign Exchange Rate Adjustments | 13.06 | -1.76 | - | 0.01 |
| Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 |
| Net Cash Flow | -4,469 | 4,631 | -6,313 | 565.48 |
| Free Cash Flow | -15,593 | -37,501 | -15,613 | -9,956 |
| Free Cash Flow Margin | -23.21% | -56.20% | -15.72% | -7.37% |
| Free Cash Flow Per Share | -550.81 | -1324.66 | -551.49 | -406.47 |
| Cash Interest Paid | 1,015 | 188.64 | 13.78 | 25.75 |
| Cash Income Tax Paid | -954.75 | -592.59 | 2,336 | 5,503 |
| Levered Free Cash Flow | -5,640 | -32,065 | -17,787 | - |
| Unlevered Free Cash Flow | -5,005 | -31,947 | -17,779 | - |
| Change in Net Working Capital | -6,887 | 7,258 | 4,298 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.